Clinical Trial Update: Psilocybin for Opioid Use Disorder (OUD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate psilocybin for Opioid Use Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING